Welcome to the Connect Ovar Coffee Information Series, the show that brings you hope and inspires you to embrace the spirit of OVARCOMING!
Each month, we deliver the latest & greatest information on progress and advances in ovarian cancer screening, diagnosis, treatment, and survivorship. The information shared by our Experts in this Series apply widely to the entire spectrum of ovarian cancer experience.
Delivered via Video as well as Podcast, we invite you to Connect Ovar Coffee with us!
Thank You to our Global Audience
Partial List of Locations
USA
Canada
United Kingdom
Russia
Israel
New Zealand
Maldives
Spain
Austria
Singapore
Indonesia
France
Bangladesh
Australia
India
Portugal
Germany
Taiwan
Mexico
South Korea
Brazil
Switzerland
Philippines
Turkey
Netherlands
Egypt
Connect Ovar Coffee Videos: 2024
Future Forward Therapies in Ovarcoming in Ovarian Cancer:
Dr. Kathleen Moore
Learning About Ovarian Cancer:
Dr. Alejandro Rauh-Hain
Optimizing Nutrition in Ovarcoming Ovarian Cancer: Karen Smith, Certified Nutritionist
Future Forward Breakthroughs in Ovarian Cancer: Dr. Amir Jazaeri
Hope on the Horizon in Ovarian Cancer: Dr. Marta Crispens
Role of Diet & Nutrition in Ovarcoming Ovarian Cancer: Christie Siebel, Sr. Dietitian
New Advances in Research & Treatment in Ovarian Cancer: Dr. Anil Sood
Advances in Immunotherapy in Ovarian Cancer: Dr. Kunle Odunsi
Benefits of Yoga Therapy in Ovarian Cancer: Dr. Lois Ramondetta and Smitha Mallaiah
The Promise of Pathbreaking Advances in Ovarian Cancer with Nanomedicine: Dr. Daniel heller
Understanding and Navigating Clinical Trials in Ovarcoming Ovarian Cancer: Dr. Premal Thaker
Celebrating 100 episodes of Connect Ovar Coffee: Featuring Dr. Rob Coleman
Advances and updates in Rare Ovarian Cancers: Dr. Rachel Grisham
Latest Advances in Ovarian Cancer Treatment & Management: Dr. Nita Lee
In progress. Please send us an email at info@ovarcome.orgwith your interest for the longer stay home option. We will share the reservation details with you.
Thank You for your interest. OvarCare is a one time grant only.